Please login to access the CRTOnline Presentations.
CRTonline.org
FDA approves Orsiro stent for commercial use
The U.S. Food and Drug Administration (FDA) approved the Orsiro drug-eluting stent (DES) system for commercial use, according stent manufacturer Biotronik announced in a news release Friday.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details